Skip to main content
Biocartis Group NV logo

Biocartis Group NV — Investor Relations & Filings

Ticker · BCART ISIN · BE0974281132 LEI · 549300J4HOJL5KG8HY54 BR Manufacturing
Open in API
Filings indexed 636 across all filing types
Latest filing 2016-11-28 Major Shareholding Noti…
Country BE Belgium
Listing BR BCART

About Biocartis Group NV

https://www.biocartis.com/en

Biocartis Group NV is a molecular diagnostics company that develops and commercializes its proprietary Idylla™ platform. This fully automated, sample-to-result system is designed to provide fast, easy, and actionable molecular diagnostic results, making advanced testing accessible to laboratories of any size. The company's primary focus is in the field of oncology, offering a menu of tests that support the diagnosis and treatment of various cancers, including lung, colorectal, melanoma, and breast cancer. Biocartis aims to enable personalized medicine for patients by providing universal access to molecular testing. The company also collaborates with pharmaceutical partners in the development of companion diagnostics.

Recent filings

Filing Released Lang Actions
Transp notif DHAM nv ENG FINAL.pdf
Major Shareholding Notification Classification · 98% confidence The document is a press release dated November 28, 2016, titled 'Disclosure of a transparency notification.' It explicitly references the 'Belgian Act of 2 May 2007 on the disclosure of major shareholdings' and details a change in shareholding percentage (crossing below the 3% threshold) by DHAM NV. This content directly relates to notifications regarding changes in significant share ownership levels, which aligns perfectly with the definition for Major Shareholding Notification (MRQ). The document length (3982 chars) is not indicative of a full report, but the content is a specific regulatory disclosure about share ownership changes, not just an announcement of a report (RPA/RNS).
2016-11-28 English
Transp notif DHAM nv NL FINAL.pdf
Major Shareholding Notification Classification · 98% confidence The document is a press release ('PERSBERICHT GEREGLEMENTEERDE INFORMATIE') announcing the receipt of a 'transparantiekennisgeving' (transparency notification) regarding a change in significant shareholding, specifically that a holding has fallen below the 3% threshold, as mandated by Belgian law ('Belgische Wet van 2 mei 2007 op openbaarmaking van belangrijke deelnemingen'). This type of notification, detailing changes in ownership thresholds by major shareholders, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a press release, the core content is the notification itself, not just an announcement of a report's publication (RPA) or a general regulatory filing (RNS).
2016-11-28 Dutch
Article 596 Auditor Report_ENG.pdf
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled "Statutory auditor's report in accordance with article 596 of the Belgian Company Code" and contains an opinion from Deloitte regarding the financial information in an attached special report concerning a capital increase and cancellation of preferential subscription rights. This structure—a formal report from an auditor reviewing management's proposal related to financial structure changes—aligns best with the definition of an Audit Report / Information (AR), which covers standalone audit reports and applied accounting principles, distinct from a full Annual Report (10-K) or a general Earnings Release (ER). Although it relates to a capital change (CAP), the core document type is the auditor's verification report.
2016-11-21 English
Article 596 Auditor Report_DUTCH.pdf
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled 'Verslag van de commissaris in het kader van artikel 596 van het Wetboek van Vennootschappen' (Report of the commissioner in the context of Article 596 of the Companies Code). This report concerns the lifting of pre-emptive rights ('opheffing van het voorkeurrecht') for a capital increase via a private placement. This activity—a formal report by an auditor/commissioner regarding a specific corporate action (capital change/financing)—fits best under the 'Capital/Financing Update' (CAP) category, as it directly relates to a capital structure change and the required statutory report supporting it. While it is an audit-like report, the context is purely transactional financing, making CAP more specific than AR (Audit Report/Information). It is not a full Annual Report (10-K) or a general Audit Report (AR).
2016-11-21 Dutch
Article 596 Report_ENG.pdf
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled a "SPECIAL REPORT OF THE BOARD OF DIRECTORS IN ACCORDANCE WITH ARTICLE 596 OF THE BELGIAN COMPANIES CODE". This report details a proposal to increase share capital via a private placement, involving the dis-application of preferential subscription rights. This type of document, which is a formal report from the Board explaining a significant corporate action (capital change/financing) and justifying the deviation from standard shareholder rights under specific national corporate law (Belgian Companies Code), aligns best with a document related to capital structure changes or financing activities. Since it is a detailed report explaining the rationale for a capital increase and the associated legal procedures, it fits the 'Capital/Financing Update' (CAP) category, which covers fundraising and capital structure changes. It is not a standard 10-K, an ER, or a simple announcement (RPA/RNS), but a comprehensive legal/board report on the proposed financing structure.
2016-11-21 English
Article 596 Report_DUTCH.pdf
Capital/Financing Update Classification · 98% confidence The document is titled "BIJZONDER VERSLAG VAN DE RAAD VAN BESTUUR OVEREENKOMSTIG ARTIKEL 596 VAN HET WETBOEK VAN VENNOOTSCHAPPEN" (Special Report of the Board of Directors pursuant to Article 596 of the Companies Code). It details a proposal by the Board of Directors to increase the company's capital through a private placement, involving the cancellation of existing shareholders' pre-emptive rights. This type of document, which is a detailed report from the board explaining a significant corporate action (capital increase/financing) and justifying the deviation from standard shareholder rights (pre-emptive rights), strongly aligns with a document related to financing activities or capital structure changes, but it is presented as a formal report required by corporate law (Article 596). Since it is a detailed report justifying a capital increase and the associated cancellation of pre-emptive rights, it fits best under 'Capital/Financing Update' (CAP) as the core subject is a proposed capital increase via private placement. While it is a formal report, it is not a general Annual Report (10-K) or a standard Interim Report (IR). It is a specific report detailing a capital action, making CAP the most appropriate fit over a general Regulatory Filing (RNS). The document length is substantial (44,557 chars), confirming it is the report itself, not just an announcement of a report (RPA).
2016-11-21 Dutch

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.